GET DAILY SIGNALSWhy Is National Vision Holdings (EYE) Stock Down -22% Today?
Key Takeaways
- National Vision Holdings (EYE) shares plunged 22.13% to close at $16.31 from the previous close of $20.94.
- The sell-off followed Q1 2026 earnings release showing an EPS beat of $0.45 vs. $0.43 expected, but revenue miss of $543.9 million vs. $545.13 million anticipated.
- Adjusted operating margin expanded 210 basis points to 10.2%, highlighting profitability gains amid cost discipline.
- Trading volume surged to over 7.8 million shares, far above the average of 1.4 million, signaling intense market reaction.
- Company reaffirmed FY2026 guidance for net revenue of $2.03-$2.09 billion and adjusted EPS of $0.85-$1.09.
- Traders watch comparable store sales trends and macroeconomic pressures on traffic next.
A Sharp Drop for National Vision Holdings (EYE)
I've been keeping an eye on EYE, the optical retailer behind over 1,300 stores like America's Best and Eyeglass World. In the latest session, shares fell 22.13%, closing at $16.31 after the prior close of $20.94. This move came right after a Q1 earnings report that mixed profitability strength with a revenue shortfall—investors zeroed in on the miss, even as margins improved.
Breaking Down the Q1 Numbers
National Vision posted Q1 net revenue of $543.9 million, a 6.6% year-over-year increase, but it came in just under the $545.13 million consensus estimate. Adjusted comparable store sales grew 4.5%, in line with mid-single-digit expectations, despite headwinds from weather and macro factors hitting cash-pay customers. On the profitability side, things looked solid: adjusted operating income reached $55.5 million, with margins expanding 210 basis points to 10.2%. Adjusted diluted EPS came in at $0.45, beating the $0.43 forecast and improving from $0.34 a year ago. From what I see, the market's reaction overlooked these gains from premium products and cost controls in favor of the top-line disappointment.
Full-Year Guidance Stays the Course
The team reaffirmed its FY2026 outlook, with net revenue projected at $2.03-$2.09 billion and adjusted diluted EPS at $0.85-$1.09. They plan 30-35 new stores, primarily America's Best, offset by 10-15 closures for net growth of 20-25 units. Capex is set at $73-$78 million to fund modernization efforts, even as e-commerce competition pressures traffic. One thing that stands out is their confidence in executing amid these challenges.
Trading Volume and Broader Market Signals
Volume spiked to over 7.8 million shares—more than five times the 1.4 million average—showing the strong selling pressure after earnings. This contrasted with peers: the consumer discretionary ETF XLY stayed near flat, while staples ETF XLP ticked higher. Shares opened at $18.99 and gapped down, breaking support near $20.66 to reach a 52-week low around $14.75. I also checked this using Tickeron’s AI Screener to compare EYE against retail peers, and the technical breakdown fits the sector's cautious tone.
Spotlight on Trending AI Robots
In my own trading research, I often turn to Tickeron’s Trending AI Robots page, which tracks the platform’s top AI-driven bots in live markets. Scanning thousands of tickers, it highlights leaders in risk-adjusted returns across strategies like trend-following, mean reversion, and momentum. Each shows timeframe, win rate, average return, and symbols traded, so you can filter by metrics or assets. I've found it useful for spotting proven performers to potentially add to my approach—worth checking out if you're evaluating automated edges.
What's Ahead for EYE
I'm watching Q2 comparable store sales closely for signs of continued mid-single-digit growth, especially with premiumization underway. Broader retail traffic and spending data could shift sentiment soon. Analyst views remain steady for now, though inflation and e-commerce risks persist. The next earnings in August will be key for testing guidance, particularly on store growth and margins in this uneven environment. This is important because it could clarify if the sell-off presents a longer-term opportunity.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
Contributor
EYE's Stochastic Oscillator entering oversold zone
The Stochastic Oscillator for EYE moved into oversold territory on October 28, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The 10-day moving average for EYE crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.
Following a +2.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where EYE advanced for three days, in 203 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
EYE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 173 of 263 cases where EYE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
Bearish Trend Analysis
The 10-day RSI Indicator for EYE moved out of overbought territory on October 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 27 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Momentum Indicator moved below the 0 level on October 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EYE as a result. In 57 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.
The Moving Average Convergence Divergence Histogram (MACD) for EYE turned negative on October 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 31 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 69%.
EYE moved below its 50-day moving average on October 27, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EYE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.363) is normal, around the industry mean (2.326). P/E Ratio (24.540) is within average values for comparable stocks, (16.930). EYE's Projected Growth (PEG Ratio) (0.050) is slightly lower than the industry average of (1.159). Dividend Yield (0.000) settles around the average of (0.095) among similar stocks. P/S Ratio (0.657) is also within normal values, averaging (1.057).
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. EYE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EYE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
an operator of retail locations offering eye exams, eyeglasses and contact lenses
Industry SpecialtyStores
Advertisement